Cancer Res Treat.  2005 Jun;37(3):143-147.

The Surgeon's Expertise-Outcome Relationship in Gastric Cancer Surgery

• Yu W
• Yun YK
• Whang I
• Choi GS

Abstract

PURPOSE
The surgical caseload or duration of practice of a surgeon may influence the outcomes of gastric cancer surgery. This study aimed to clarify the surgical quality provided by specialized gastric cancer surgeons. MATERIALS AND METHODS: The postoperative courses of 1, 877 patients who underwent surgery for gastric cancer were retrospectively reviewed. For classification of the surgeon's expertise, the number of yearly resections performed by, and consecutive years of practice of, the surgeons were used. The outcome measures used were the 30-day mortality and long-term survival. RESULTS: Surgical mortalities of patients who underwent surgery by a specialized surgeon and those by a general surgeon revealed no statistically significant difference. A significant difference in the five-year survival rates was found with surgeons with at least two consecutive years of practice compared to those with less than two years, when 50 or more cases had been conducted per year (63.9% and 59.7%; p=0.0380). In cases of four-years of consecutive practice, the five-year survival rate was significantly improved, even if only 10 cases were performed annually (64.9% and 58.3%; p=0.0023), although the best survival rate was found with surgeons that had performed 50 or more surgeries per year. CONCLUSION: Improved survival rates, with acceptable surgical mortality, can be achieved for gastric cancer when the surgery is performed by a specialized surgeon. A specialized gastric cancer surgeon can be defined as one who has operated on more than 50 new cases per year, with 2 or more consecutive years of surgical practice.

Keyword

Stomach neoplasms; Gastrectomy; Prognosis; Surgeon volume

MeSH Terms

Classification
Gastrectomy
Humans
Mortality
Outcome Assessment (Health Care)
Prognosis
Retrospective Studies
Stomach Neoplasms*
Survival Rate

Reference

1. Hermanek P, Hohenberger W. The importance of volume in colorectal cancer surgery. Eur J Surg Oncol. 1996; 22:213–215. PMID: 8654598.

2. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg. 1998; 227:157–167. PMID: 9488510.

3. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000; 18:2327–2340. PMID: 10829054.

4. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ. 1991; 302:1501–1505. PMID: 1713087.

5. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg. 2002; 89:1008–1013. PMID: 12153626.

6. Meagher AP. Colorectal cancer: is the surgeon a prognostic factor? A systematic review. Med J Aust. 1999; 171:308–310. PMID: 10560448.

7. Sainsbury R, Haward B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet. 1995; 345:1265–1270. PMID: 7746056.

8. Gillison EW, Powell J, McConkey CC, Spychal RT. Surgical workload and outcome after resection for carcinoma of the oesophagus and cardia. Br J Surg. 2002; 89:344–348. PMID: 11872061.

9. Edge SB, Schmieg RE, Rosenlof LK, Wilhelm MC. Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer. 1993; 71:3502–3508. PMID: 8098265.

10. Munoz E, Mulloy K, Goldstein J, Tenenbaum N, Wise L. Costs, quality, and the volume of surgical oncology procedures. Arch Surg. 1990; 125:360–363. PMID: 2106311.

11. Kelly JV, Hellinger FJ. Physician and hospital factors associated with mortality of surgical patients. Med Care. 1986; 24:785–800. PMID: 3762245.

12. Hermanek P, Sobin LH. UICC TNM classification of malignant tumors. 1992. 4th edition. Berlin: Springer;2nd revision.

13. Fielding LP. Surgeon-related variability in the outcome of cancer surgery. J Clin Gastroenterol. 1988; 10:130–132. PMID: 3047213.

14. Stocchi L, Nelson H, Sargent DJ, O'Connell MJ, Tepper JE, Krook JE, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol. 2001; 19:3895–3902. PMID: 11559727.

15. Moriwaki Y, Kobayashi S, Kunisaki C, Harada H, Imai S, Kido Y, et al. Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator? Dig Surg. 2001; 18:111–117. PMID: 11351155.

16. McCulloch P. D1 versus D2 dissection for gastric cancer. Lancet. 1995; 345:1516–1518. PMID: 7769934.

17. Parikh D, Johnson M, Chagla L, Lowe D, McCulloch P. D2 gastrectomy: lessons from a prospective audit of the learning curve. Br J Surg. 1996; 83:1595–1599. PMID: 9014684.

18. Hartgrink HH, Bonenkamp HJ, van de Velde CJ. Influence of surgery on outcomes in gastric cancer. Surg Oncol Clin N Am. 2000; 9:97–117. PMID: 10601527.

19. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995; 345:745–748. PMID: 7891484.

20. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med. 1999; 340:908–914. PMID: 10089184.

21. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. The Surgical Cooperative Group. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet. 1996; 347:995–999. PMID: 8606613.

22. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Surgical Co-operative Group. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer. 1999; 79:1522–1530. PMID: 10188901.

23. Barchielli A, Amorosi A, Balzi D, Crocetti E, Nesi G. Long-term prognosis of gastric cancer in a European country: a population-based study in Florence (Italy). 10-year survival of cases diagnosed in 1985-1987. Eur J Cancer. 2001; 37:1674–1680. PMID: 11527695.

24. Maehara Y, Watanabe A, Kakeji Y, Emi Y, Moriguchi S, Anai H, et al. Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. Br J Cancer. 1992; 65:417–420. PMID: 1558797.

25. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer. 1993; 72:2089–2097. PMID: 8374867.